about
Review and uses of stereotactic body radiation therapy for oligometastasesExtreme hypofractionation for early prostate cancer: Biology meets technology.High-intensity focused ultrasound plus concomitant radiotherapy: a new weapon in oncology?Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients.The Pocketable Electronic Devices in Radiation Oncology (PEDRO) Project: How the Use of Tools in Medical Decision Making is Changing?Overall and disease-free survival greater than 12 years in metastatic non-small cell lung cancer after linear accelerator-based stereotactic radiosurgery for solitary brain metastasis.Temozolomide combined with radiotherapy in the treatment of recurrent cranial meningioma previously treated with multiple surgical resections and two sessions of radiosurgery: a case report and literature review.Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment.Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments.Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: report of dosimetric and early clinical results in oligometastatic patients.SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience.Dosimetric impact of inter-observer variability for 3D conformal radiotherapy and volumetric modulated arc therapy: the rectal tumor target definition case.Remission of refractory neurosarcoidosis treated with brain radiotherapy: a case report and a literature review.Adenoid cystic carcinoma of trachea treated with adjuvant hypofractionated tomotherapy. Case report and literature review.Initial experience of hypofractionated radiation retreatment with true beam and flattening filter free beam in selected case reports of recurrent nasopharyngeal carcinoma.A strategy for young members within national radiation oncology societies: the Italian experience (AIRO Giovani group).Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments.Postoperative radiotherapy in prostate cancer: acquired certainties and still open issues. A review of recent literature.Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review.Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: a review.Salvage therapy of small volume prostate cancer nodal failures: a review of the literature.From radiobiology to technology: what is changing in radiotherapy for prostate cancer.Choline-PET in prostate cancer management: the point of view of the radiation oncologist.Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era.Surgery or stereotactic ablative radiation therapy: how will be treated operable patients with early stage not small cell lung cancer in the next future?Is high dose rate brachytherapy reliable and effective treatment for prostate cancer patients? A review of the literature.Available evidence on re-irradiation with stereotactic ablative radiotherapy following high-dose previous thoracic radiotherapy for lung malignancies.Impact of weight loss in patients with head and neck carcinoma undergoing radiotherapy: is it an underestimated phenomenon? A radiation oncologist's perspective.Lymph-node relapsed prostate cancer management and PET-driven external beam radiotherapy: salvage or palliative treatment?"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer?A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective.Spinal metastases: Is stereotactic body radiation therapy supported by evidences?SBRT and extreme hypofractionation: A new era in prostate cancer treatments?What is changing in radiotherapy for the treatment of locally advanced nonsmall cell lung cancer patients? A review.Adult prostatic sarcoma: A contemporary multicenter Rare Cancer Network study.Surprising complete response of intramedullary spinal cord metastasis from breast cancer: a case report and literature review.Radiotherapy in patients with connective tissue diseases.
P50
Q26864247-1661E438-927B-4B7C-9D16-02AA02031696Q30245344-226CF2C8-CFF9-40C1-A66E-DB07A3A5356AQ30440011-15A624F1-423B-4058-B92C-5838849FABBFQ33398899-352F8296-F525-4A88-AB97-7ED5AF9D7B0FQ33442985-9F390A14-C31D-4B97-8733-9E04256DC688Q34296681-F3BF7D3F-D153-45A7-A9B8-D91C57F1ED7FQ34349003-676A41FA-D7FC-45B3-AEF5-7DB635D4BB25Q34568221-F176B8B6-00D1-4013-9885-7A35DA5EAABEQ35232033-E9BE2092-6F9F-4294-9897-727395B67AEEQ36368120-ED3698B6-EA52-4120-AF89-3C5FB4408B29Q36452278-2B1630A5-7B74-408B-B95E-5A3DA09D5426Q36535570-2F1B7E10-FBC3-46C6-BEED-114583E455D2Q36552596-9B3B2651-AB82-4886-B81B-6F72C4E79333Q37000899-C3DF93F3-2F3B-46E7-9A37-1704C41F7220Q37038061-E32007D0-D0D1-4A65-A5C4-AAF7143CA4D6Q37107145-5EB0B871-B893-49C7-8BCC-FE0A3F7E9667Q37158585-60C1E504-BFFA-414A-A04C-3377073D5EA0Q37453956-AB0F03CD-C11B-4E64-AB21-7C5B65805D0FQ37453969-B85DE230-09CD-4A18-A84D-6EE3662973B7Q37723610-E663AF36-0F5A-40FF-A6A3-DDE01F1A4DA3Q37870119-D06BC703-0EC1-4F89-AC6B-09DB098A9374Q37976903-37E0E0B3-F5C9-4265-8ED9-C775A704578CQ38129578-BEA1F9BE-3385-4571-8B56-B098199FD593Q38169396-738023AD-F3A6-4E51-9493-125765FF1BAEQ38191990-239B59CD-CB8B-4C44-B42B-0EE95372FE77Q38210611-F24B335C-B933-4786-9A1D-C34EF11200DDQ38280403-52BCBA7A-B790-43AF-A5F4-0213CB05F514Q38367507-A011C5A9-DB89-4E8E-B0B8-C39876FDDFFEQ38394713-BA36FA17-E7F3-4D17-9F43-9AAD1625BE10Q38443076-CAFA4883-78EC-4910-9B15-8DF16A333280Q38446588-DB5CC1A5-6CFF-415D-9F96-7DE3DF4043B8Q38578471-91BE86A4-F0C8-41B1-AB26-DEAD7DA9AECFQ38587821-E1DD79A0-B445-46CD-9D0F-6DFA8C7154E6Q38604232-A0432465-0752-4E33-9D13-AF9C6AEB936AQ38644286-5D94BE52-B3FF-4494-905E-B8E0DDF8CC7BQ38677018-1E02083B-D7C3-4E66-8414-01E2EAADC0A8Q38711723-C65543FB-D065-4B28-B0D1-6B19E12E1C6AQ38736782-D688EE3E-9F93-4A77-BD65-EF97F12318B6Q38749154-DCCDB5A4-6AE9-4B1B-B519-F744C3D678DAQ38773196-5ACA6E4C-738C-417E-AFF8-2EB09B8F7F9E
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Filippo Alongi
@ast
Filippo Alongi
@en
Filippo Alongi
@es
Filippo Alongi
@nl
Filippo Alongi
@sl
type
label
Filippo Alongi
@ast
Filippo Alongi
@en
Filippo Alongi
@es
Filippo Alongi
@nl
Filippo Alongi
@sl
prefLabel
Filippo Alongi
@ast
Filippo Alongi
@en
Filippo Alongi
@es
Filippo Alongi
@nl
Filippo Alongi
@sl
P106
P1153
23972586900
P31
P496
0000-0002-6569-8628